GLP-1 drugs are effective for weight loss but face shortages and high costs. Dr. Timothy Law believes doctors should make the call on which patients get access, not insurers. Dr. Melanie Jay disagrees, saying individual providers can’t ensure health equity. Law thinks the responsibility should be on pharmaceutical companies to increase supply and lower prices. Insurers, like Blue Cross Blue Shield of Michigan, are reevaluating their coverage policies for GLP-1 drugs. Highmark is considering a tiered approach for coverage. The debate continues on who should decide on access to GLP-1 drugs and how to make them more available and affordable.
Source link
Who Should Be Responsible for Rationing GLP-1s?
